Swiss National Bank Revolution Medicines, Inc. Transaction History

Swiss National Bank

$146 Billion
Q4 2024

A detailed history of Swiss National Bank transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Swiss National Bank holds 229,931 shares of RVMD stock, worth $8.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

229,931

Previous 225,531 1.95%

Holding current value

$8.91 Million

Previous $10.2 Million 1.58%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$42.97 - $60.6 $189,068 - $266,640	4,400 Added 1.95%	229,931 $10.1 Million
Q3 2024 Nov 07, 2024	SELL	$36.92 - $47.94 $47,996 - $62,322	-1,300 Reduced 0.57%	225,531 $10.2 Million
Q2 2024 Aug 08, 2024	BUY	$30.14 - $40.68 $804,738 - $1.09 Million	26,700 Added 13.34%	226,831 $8.8 Million
Q4 2023 Feb 06, 2024	BUY	$18.35 - $34.12 $670,343 - $1.25 Million	36,531 Added 22.33%	200,131 $5.74 Million
Q3 2023 Nov 08, 2023	BUY	$25.17 - $35.05 $45,306 - $63,089	1,800 Added 1.11%	163,600 $4.53 Million
Q2 2023 Aug 09, 2023	SELL	$20.28 - $27.0 $137,904 - $183,600	-6,800 Reduced 4.03%	161,800 $4.33 Million
Q1 2023 May 10, 2023	BUY	$20.76 - $30.09 $421,428 - $610,827	20,300 Added 13.69%	168,600 $3.65 Million
Q4 2022 Feb 08, 2023	BUY	$17.68 - $25.53 $106,080 - $153,180	6,000 Added 4.22%	148,300 $3.53 Million
Q3 2022 Nov 09, 2022	BUY	$17.46 - $26.0 $665,226 - $990,600	38,100 Added 36.56%	142,300 $2.81 Million
Q2 2022 Aug 09, 2022	SELL	$14.54 - $27.17 $130,859 - $244,530	-9,000 Reduced 7.95%	104,200 $2.03 Million
Q1 2022 May 09, 2022	BUY	$17.31 - $26.4 $133,287 - $203,280	7,700 Added 7.3%	113,200 $2.89 Million
Q3 2021 Nov 08, 2021	BUY	$23.95 - $33.41 $50,295 - $70,161	2,100 Added 2.03%	105,500 $2.9 Million
Q2 2021 Aug 06, 2021	BUY	$29.0 - $47.44 $1.68 Million - $2.75 Million	57,900 Added 127.25%	103,400 $3.28 Million
Q1 2021 May 07, 2021	BUY	$37.21 - $54.43 $29,768 - $43,544	800 Added 1.79%	45,500 $2.09 Million
Q4 2020 Feb 05, 2021	BUY	$30.19 - $45.49 $256,615 - $386,665	8,500 Added 23.48%	44,700 $1.77 Million
Q3 2020 Nov 09, 2020	BUY	$22.61 - $34.8 $223,839 - $344,520	9,900 Added 37.64%	36,200 $1.26 Million
Q2 2020 Aug 05, 2020	BUY	$19.65 - $39.34 $516,794 - $1.03 Million	26,300 New	26,300 $830,000

Others Institutions Holding RVMD

# of Institutions

299

Shares Held

179M

Call Options Held

920K

Put Options Held

1.06M

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.4B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Revolution Medicines, Inc. Transaction History